Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Coverage | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 117K | 378.97 | $ 44.34M |
3/31/2025 | $ 117K | 267.38 | $ 31.28M |
12/31/2024 | $ 56K | 694.96 | $ 38.92M |
9/30/2024 | $ 85K | 397.25 | $ 33.77M |
6/30/2024 | $ 92K | 362.42 | $ 33.34M |
3/31/2024 | $ 140K | 254.37 | $ 35.61M |
12/31/2023 | $ 140K | 192.92 | $ 27.01M |
9/30/2023 | $ 95K | 255.13 | $ 24.24M |
6/30/2023 | $ 68K | 454.13 | $ 30.88M |
3/31/2023 | $ 0 | 0 | $ 13.71M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / CapEx
(=) CapEx Coverage
CapEx Coverage for PUMA BIOTECHNOLOGY INC is calculated as follows: CF - Operations [ $ 7.97M ] / CapEx [ $ 329K ]
(=) CapEx Coverage [ 24.24 ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 2.21K |
---|---|
min | 0.01 |
max | 17.91 |
average | 4.42 |
median | 3.01 |
std | 4.02 |